Imaging Gives Clearer Picture of Cancer Drugs' Chances of Success
The quest for new cancer treatments could be revolutionised by advances in technology that can visualise living cells and tissues, scientists claim. Leading edge imaging techniques will make it easier to identify which are the most promising new drugs to take forward for patient testing, a review of the technology suggests. Applying such techniques early in the drug discovery process could improve the success rate of new medicines by helping to rule out drugs that are unlikely to work.
Read more ...
What mHealth Can Do for You
Neelie Kroes, Vice-President of the European Commission, responsible for the Digital Agenda, said: "mHealth is just one of the benefits of a #ConnectedContinent - helping patients, doctors and carers take control, wherever they are. From simple apps which help you stick to your exercise regime - to monitoring tools for those on kidney dialysis. I am delighted that the EU is so committed to this fascinating area. The EU has already invested over €100 million, with about €95 million up for grabs over the next two years. And we are now consulting on how best to unlock the huge potential of mobile healthcare."
Read more ...
eHealth in the EU: What's the Diagnosis?
"Europe is facing a healthcare crunch as a result of our ageing population. By making the most use of digital tech, we can reduce costs, put the patient back in control, make healthcare more efficient and help European citizens to take an active part in society for longer. We have to keep our finger on the pulse!" - Neelie Kroes.
Read more ...
The Human Brain Project Just Got Bigger
One of the biggest EU-funded initiatives, the Human Brain Project (HBP), today announced the beneficiaries of its €8.3 million competitive call for new partners. 32 organisations from 13 countries - Austria, Belgium, Cyprus, Finland, France, Germany, Israel, Italy, Netherlands, Slovenia, Spain, Switzerland and the UK - will join the partnership. This represents a 40% increase in the number of partners in the HBP consortium.
Read more ...
New IMI Project to Incorporate Real Life Data into Drug Development
The Innovative Medicines Initiative (IMI) has launched a new project called GETREAL that will investigate new ways of integrating data from real life settings, such as clinics, into drug development. This will assist healthcare decision makers when deciding how best to grant patients access to a new treatment and help pharmaceutical companies to take better decisions during drug development.
Read more ...
Antilope Calls for Development of eHealth Testing Tools
Today the EU-funded Antilope project published a request for proposals (RFP) for developing testing tools that further enhance testing for the profiles and standards needed to implement the use cases identified in the European eHealth Interoperability Framework (eEIF). These new testing tools will serve to further advance eHealth interoperability in Europe. The Antilope project has published a list of testing tools that are used to ensure interoperability with existing IT infrastructures, services and devices.
Read more ...
Phantom Limb Pain Relieved with Augmented Reality
Researcher at Chalmers University of Technology, University of Gothenburg and Sahlgrenska University Hospital has developed a new method for the treatment of phantom limb pain (PLP) after an amputation. The method is based on a unique combination of several technologies, and has been initially tested on a patient who has suffered from severe phantom limb pain for 48 years. A case study shows a drastic reduction of pain.
Read more ...
Neelie Kroes, Vice-President of the European Commission, responsible for the Digital Agenda, said: "mHealth is just one of the benefits of a #ConnectedContinent - helping patients, doctors and carers take control, wherever they are. From simple apps which help you stick to your exercise regime - to monitoring tools for those on kidney dialysis. I am delighted that the EU is so committed to this fascinating area. The EU has already invested over €100 million, with about €95 million up for grabs over the next two years. And we are now consulting on how best to unlock the huge potential of mobile healthcare." 
The Innovative Medicines Initiative (IMI) has launched a new project called GETREAL that will investigate new ways of integrating data from real life settings, such as clinics, into drug development. This will assist healthcare decision makers when deciding how best to grant patients access to a new treatment and help pharmaceutical companies to take better decisions during drug development.